- Home
- INOD vs ANIP Comparison
INOD vs ANIP Comparison
Compare INOD & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- ANIP
- Stock Information
- Founded
- INOD 1988
- ANIP 2001
- Country
- INOD United States
- ANIP United States
- Employees
- INOD N/A
- ANIP N/A
- Industry
- INOD EDP Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- INOD Technology
- ANIP Health Care
- Exchange
- INOD Nasdaq
- ANIP Nasdaq
- Market Cap
- INOD 1.2B
- ANIP 1.2B
- IPO Year
- INOD 1993
- ANIP N/A
- Fundamental
- Price
- INOD $36.78
- ANIP $58.46
- Analyst Decision
- INOD Strong Buy
- ANIP Buy
- Analyst Count
- INOD 4
- ANIP 7
- Target Price
- INOD $36.50
- ANIP $77.33
- AVG Volume (30 Days)
- INOD 1.5M
- ANIP 257.7K
- Earning Date
- INOD 02-20-2025
- ANIP 02-27-2025
- Dividend Yield
- INOD N/A
- ANIP N/A
- EPS Growth
- INOD N/A
- ANIP N/A
- EPS
- INOD 0.62
- ANIP N/A
- Revenue
- INOD $137,393,000.00
- ANIP $555,456,000.00
- Revenue This Year
- INOD $93.11
- ANIP $25.48
- Revenue Next Year
- INOD $34.30
- ANIP $20.24
- P/E Ratio
- INOD $59.19
- ANIP N/A
- Revenue Growth
- INOD 71.66
- ANIP 23.60
- 52 Week Low
- INOD $5.46
- ANIP $52.50
- 52 Week High
- INOD $55.17
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- INOD 46.54
- ANIP 62.05
- Support Level
- INOD $32.54
- ANIP $52.74
- Resistance Level
- INOD $46.69
- ANIP $55.21
- Average True Range (ATR)
- INOD 3.01
- ANIP 1.54
- MACD
- INOD -0.70
- ANIP 0.48
- Stochastic Oscillator
- INOD 29.96
- ANIP 98.11
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.